4BA-14482-92258
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 222 / VA
- Registered
- 2021-11-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-11-23
Dose 3 — Pfizer-BioNTech
-
2021-11-24
Registered in v-safe
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-26
- 2021-11-29
- 2021-12-16
- 2021-12-30
- 2022-01-04
-
2022-02-22
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: FairFree text: CovidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | No |
| 2 | 2021-04-30 | Pfizer-BioNTech | No |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release